<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A young adult man with Klippel-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Tr</z:e>énaunay syndrome presented to our pain management service with complaints of severe lower extremity neuropathic pain (pain scale 8 of 10 on the left and 4 of 10 on the right) </plain></SENT>
<SENT sid="1" pm="."><plain>The pain in his left leg was so severe that he wanted to undergo a left lower extremity <z:mpath ids='MPATH_686'>amputation</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>The patient declined <z:hpo ids='HP_0011010'>chronic</z:hpo> use of narcotic medications for pain relief, believing that this would interfere with his educational and lifestyle pursuits </plain></SENT>
<SENT sid="3" pm="."><plain>After a complete evaluation for possible sources of pain, we performed a trial placement of a spinal cord stimulator at the T9 level, which relieved his pain </plain></SENT>
<SENT sid="4" pm="."><plain>We then placed a stimulator at the T10 level </plain></SENT>
<SENT sid="5" pm="."><plain>At 1 year postimplantation, he was pain free (pain scale 1 of 10 bilaterally) and was able to function normally without narcotic support </plain></SENT>
<SENT sid="6" pm="."><plain>We believe this to be the first use of a spinal cord stimulator for lower extremity pain resulting from Klippel-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Tr</z:e>énaunay syndrome </plain></SENT>
<SENT sid="7" pm="."><plain>We also discuss the clinical evaluation and treatment of a Klippel-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Tr</z:e>énaunay syndrome patient with <z:hpo ids='HP_0011010'>chronic</z:hpo> pain </plain></SENT>
</text></document>